Long-Term Metformin Usage and Cognitive Function among Older Adults with Diabetes
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Evidence strongly supports the important role of insulin resistance in cognitive decline and dementia and suggests that insulin sensitizers may protect against cognitive decline in diabetic and pre-diabetic individuals. Inconclusive results have been reported in clinical trials of rosiglitazone, an insulin sensitizer that also increases cardiovascular mortality risks. No study has yet reported a protective cognitive effect of metformin, an insulin-sensitizing biguanide widely used in diabetic patients. We studied 365 older persons aged 55 and over in the population-based Singapore Longitudinal Aging Study with diabetes who were followed up over 4 years. The odds ratios (OR) of association of metformin use (n = 204) versus non-use (n = 161) with cognitive impairment (Mini-Mental State Exam ≤ 23), and by duration: up to 6 years (n = 114) and more than 6 years (n = 90) were evaluated in cross-sectional and longitudinal multivariate analyses. Controlling for age, education, diabetes duration, fasting blood glucose, vascular and non-vascular risk factors, metformin use showed a significant inverse association with cognitive impairment in longitudinal analysis (OR = 0.49, 95% CI 0.25-0.95). Metformin use showed significant linear trends of association across duration of use in cross-sectional and longitudinal analyses (p = 0.018 and p = 0.002, respectively), with use for more than 6 years significantly associated with lowest risk of cognitive impairment in both cross-sectional anal…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“although some epidemiological studies supported a protective role for metformin, which crosses the BBB, in preventing cognitive decline in individuals with type 2 diabetes [304]”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [304]
In the citing paper
“In the Singapore Longitudinal Aging Study 2,365 subjects with diabetes (age ≥ 55) were monitored for 4 years – see Table 2 (116). In a cross-sectional and longitudinal multivariate analysis, odds ratios of association of the chronic use of metformin with cognitive disability (Mini-Mental State Exam ≤ 23) were evaluated demonstrating a substantial inverse relationship with cognitive impairment (116”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [116]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · cited 2×
“Metformin has also been shown to attenuate inflammation in experimental models of central inflammation by modulating proinflammatory responses in rat primary microglia cells through both AMPK-dependent and AMPK-independent mechanisms [36].”
BackgroundAppendix G: Geriatric Depression Scale
(2015) · Deep Brain Stimulation Management · doi:10.1017/cbo9781316026625.021 · Cited by 1,536
Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E. A., Frosch, M. P., Eckman, C. B., Tanzi, R. E., Selkoe, D. J., & Guénette, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0230450100 · Cited by 1,286
Type 2 Diabetes, APOE Gene, and the Risk for Dementia and Related Pathologies
Peila, R., Rodriguez, B. L., & Launer, L. J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1256 · Cited by 1,207
Kirpichnikov, D., McFarlane, S. I., & Sowers, J. R. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00009 · Cited by 1,084 · cited 1×
“This is responsible for the known effects of metformin in inhibiting hepatic glucose production, increasing insulin sensitivity, enhancing peripheral utilization of glucose (from improved insulin binding to insulin receptors), and increasing fatty acid oxidation [31], leading to improved glycemic and lipid profiles fr…”
BackgroundCognitive decline and dementia in diabetes—systematic overview of prospective observational studies
Cukierman, T., Gerstein, H. C., & Williamson, J. D. (2005) · Diabetologia · doi:10.1007/s00125-005-0023-4 · Cited by 1,049
Risner, M. E., Saunders, A. M., Altman, J. F. B., Ormandy, G. C., Craft, S., Foley, I. M., Zvartau-Hind, M. E., Hosford, D. A., Roses, A. D., & for the Rosiglitazone in Alzheimer's Disease Study Group (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500369 · Cited by 686
Watson, G. S. (2005) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.13.11.950 · Cited by 597
Diabetes, impaired fasting glucose, and development of cognitive impairment in older women
Yaffe, K., Blackwell, T., Kanaya, A. M., Davidowitz, N., Barrett-Connor, E., & Krueger, K. (2004) · Neurology · doi:10.1212/01.wnl.0000134666.64593.ba · Cited by 520
Metformin Inhibits Proinflammatory Responses and Nuclear Factor-κB in Human Vascular Wall Cells
Isoda, K., Young, J. L., Zirlik, A., MacFarlane, L. A., Tsuboi, N., Gerdes, N., Schönbeck, U., & Libby, P. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000201938.78044.75 · Cited by 499
Accumulation of Metformin by Tissues of the Normal and Diabetic Mouse
Wilcock, C., & Bailey, C. J. (1994) · Xenobiotica · doi:10.3109/00498259409043220 · Cited by 418 · cited 1×
“Metformin evidently crosses the blood-brain barrier, accumulates in the brain [34], and acts directly on the CNS.”
BackgroundNyunt, M. S. Z., Fones, C., Niti, M., & Ng, T.-P. (2009) · Aging & Mental Health · doi:10.1080/13607860902861027 · Cited by 414
Self-citationGold, M., Alderton, C., Zvartau-Hind, M., Egginton, S., Saunders, A. M., Irizarry, M., Craft, S., Landreth, G., Linnamägi, Ü., & Sawchak, S. (2010) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000318845 · Cited by 361
Craft, S. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.08.021 · Cited by 348
Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia
Yaffe, K., Falvey, C., Hamilton, N., Schwartz, A. V., Simonsick, E. M., Satterfield, S., Cauley, J. A., Rosano, C., Launer, L. J., Strotmeyer, E. S., et al. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.1117 · Cited by 313
The Origins of Alzheimer Disease: A Is for Amyloid
Selkoe, D. J. (2000) · JAMA · doi:10.1001/jama.283.12.1615 · Cited by 284
Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men
Kalmijn, S., Feskens, E. J. M., Launer, L. J., Stijnen, T., & Kromhout, D. (1995) · Diabetologia · doi:10.1007/bf00402181 · Cited by 275
El-Mir, M.-Y., Detaille, D., R-Villanueva, G., Delgado-Esteban, M., Guigas, B., Attia, S., Fontaine, E., Almeida, A., & Leverve, X. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-007-9002-1 · Cited by 244
Glucose regulation and cognitive functions: relation to Alzheimer's disease and diabetes
Messier, C., & Gagnon, M. (1996) · Behavioural Brain Research · doi:10.1016/0166-4328(95)00153-0 · Cited by 237
Niti, M., Yap, K.-B., Kua, E.-H., Tan, C.-H., & Ng, T.-P. (2007) · International Psychogeriatrics · doi:10.1017/s1041610207006655 · Cited by 198
Self-citationLinks between cognitive impairment in insulin resistance: An explanatory model
Convit, A. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.018 · Cited by 198
Ng, T.-P., Niti, M., Chiam, P.-C., & Kua, E.-H. (2007) · The American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000235710.17450.9a · Cited by 197
Self-citationHarrington, C., Sawchak, S., Chiang, C., Davies, J., Donovan, C., M. Saunders, A., Irizarry, M., Jeter, B., Zvartau-Hind, M., H. van Dyck, C., et al. (2011) · Current Alzheimer Research · doi:10.2174/156720511796391935 · Cited by 197
Cognitive Function in an Elderly Population With Persistent Impaired Glucose Tolerance
Vanhanen, M., Koivisto, K., Kuusisto, J., Mykkänen, L., Helkala, E.-L., Hänninen, T., Riekkinen, P., Soininen, H., & Laakso, M. (1998) · Diabetes Care · doi:10.2337/diacare.21.3.398 · Cited by 187
Rosiglitazone attenuates the cognitive deficits induced by high fat diet feeding in rats
Pathan, A. R., Gaikwad, A. B., Viswanad, B., & Ramarao, P. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.06.016 · Cited by 123
Insulin Resistance and Executive Dysfunction in Older Persons
Abbatecola, A. M., Paolisso, G., Lamponi, M., Bandinelli, S., Lauretani, F., Launer, L. J., & Ferrucci, L. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52466.x · Cited by 121
Insulin Resistance in Cognitive Impairment: The InCHIANTI Study
Geroldi, C., Frisoni, G. B., Paolisso, G., Bandinelli, S., Lamponi, M., Abbatecola, A. M., Zanetti, O., Guralnik, J. M., & Ferrucci, L. (2005) · Archives of Neurology · doi:10.1001/archneur.62.7.1067 · Cited by 107
Cerebral complications of diabetes: clinical findings and pathogenetic mechanisms
Biessels, G. J. (1999) · The Netherlands Journal of Medicine · doi:10.1016/s0300-2977(98)00134-x · Cited by 94
Abbatecola, A. M., Lattanzio, F., Molinari, A. M., Cioffi, M., Mansi, L., Rambaldi, P., DiCioccio, L., Cacciapuoti, F., Canonico, R., & Paolisso, G. (2010) · Diabetes Care · doi:10.2337/dc09-2030 · Cited by 93
Antiatherogenic properties of metformin: the experimental evidence
Mamputu, J., Wiernsperger, N. F., & Renier, G. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(03)72790-6 · Cited by 93
Rasgon, N., & Kenna, H. A. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.004 · Cited by 69
Łabuzek, K., Liber, S., Gabryel, B., & Okopień, B. (2010) · Pharmacological Reports · doi:10.1016/s1734-1140(10)70343-1 · Cited by 68
Wakisaka, M., Nagamachi, S., Inoue, K., Morotomi, Y., Nunoi, K., & Fujishima, M. (1990) · Journal of Diabetes and its Complications · doi:10.1016/0891-6632(90)90017-y · Cited by 46
Cited by
Metformin as a tool to target aging
Barzilai, N., Crandall, J. P., Kritchevsky, S. B., & Espeland, M. A. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.011 · Cited by 1,096
Aging and age‐related diseases: from mechanisms to therapeutic strategies
Li, Z., Zhang, Z., Ren, Y., Wang, Y., Fang, J., Yue, H., Ma, S., & Guan, F. (2021) · Biogerontology · doi:10.1007/s10522-021-09910-5 · Cited by 640
Interventions to slow aging in humans: are we ready?
Longo, V. D., Antebi, A., Bartke, A., Barzilai, N., Brown‐Borg, H. M., Caruso, C., Curiel, T. J., Cabo, R., Franceschi, C., Gems, D., et al. (2015) · Aging Cell · doi:10.1111/acel.12338 · Cited by 592
“, 2014), and possibly cognitive decline (Ng et al., 2014).”
Campbell, J. M., Bellman, S. M., Stephenson, M. D., & Lisy., K. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.08.003 · Cited by 455
Ageing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448
“For example, although some epidemiological studies supported a protective role for metformin, which crosses the BBB, in preventing cognitive decline in individuals with type 2 diabetes [304], another 12-year cohort study in patients with type 2 diabetes showed a two-fold increase in the risk of AD and PD in those who…”
Result
Metadata
- Authors
- Ng, T. P., Feng, L., Yap, K. B., Lee, T. S., Tan, C. H., & Winblad, B.
- Affiliations
- National University of Singapore (SG)
- Karolinska Institutet (SE)
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2014-06-04
- Volume
- 41
- Issue
- 1
- Pages
- 61-68
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1597817261
- Cited by
- 334
- References
- 35
- Citations by year
- 2026: 17 · 2025: 17 · 2024: 36 · 2023: 33 · 2022: 35 · 2021: 39 · 2020: 42 · 2019: 41 · 2018: 23 · 2017: 14 · 2016: 19 · 2015: 12 · 2014: 6
- FWCI
- 12.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- metformin, cognitive impairment
- MeSH terms
- Aged, Aged, 80 and over, Cognition Disorders, Cross-Sectional Studies, Diabetes Mellitus, Female, Humans, Hypoglycemic Agents, Longitudinal Studies, Male, Metformin, Middle Aged, Prospective Studies, Singapore, Time Factors, Multivariate Analysis, Linear Models, Odds Ratio
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.